Cyclodextrin-based nanosponges as promising carriers for active agents
- PMID: 30845847
- DOI: 10.1080/17425247.2019.1591365
Cyclodextrin-based nanosponges as promising carriers for active agents
Abstract
Introduction: In recent years, new drug delivery systems have attempted to overcome the undesirable pharmacokinetic problems of various drugs. Among them, cyclodextrin nanosponges (CDNSs) attract great attention from researchers for solving major bioavailability problems such as inadequate solubility, poor dissolution rate, and the limited stability of some agents, as well as increasing their effectiveness and decreasing unwanted side effects. This novel system can also be prepared as different dosage forms.
Areas covered: This review will give an insight into the effects of CDNSs on the pharmacokinetic parameters and permeability of active agents. Different classes of drugs delivered by this system are mentioned and we designate which CD is used most widely in their production process. We also inform why this carrier can be introduced as a versatile carrying system in pharmaceutical fields. Registered patents about this novel system in various fields are also mentioned.
Expert opinion: The readers will be informed on CDNSs as a novel carrier especially for the delivery of drugs. Versatile characteristics and applications of them can also be known by this review. Finally, CDNSs may be introduced as a remarkable vehicle in the pharmaceutical market in coming years.
Keywords: Cyclodextrin; Nanosponge; Permeability; Pharmaceutical; Pharmacokinetic.
Similar articles
-
Drug-Encapsulated Cyclodextrin Nanosponges.Methods Mol Biol. 2021;2207:247-283. doi: 10.1007/978-1-0716-0920-0_19. Methods Mol Biol. 2021. PMID: 33113141 Review.
-
Exploring Cyclodextrin-Based Nanosponges as Drug Delivery Systems: Understanding the Physicochemical Factors Influencing Drug Loading and Release Kinetics.Int J Mol Sci. 2024 Mar 20;25(6):3527. doi: 10.3390/ijms25063527. Int J Mol Sci. 2024. PMID: 38542499 Free PMC article. Review.
-
Cyclodextrin-based nanosponges: a propitious platform for enhancing drug delivery.Expert Opin Drug Deliv. 2014 Jan;11(1):111-20. doi: 10.1517/17425247.2014.865013. Epub 2013 Dec 4. Expert Opin Drug Deliv. 2014. PMID: 24298891 Review.
-
Cyclodextrin based nanosponges for pharmaceutical use: a review.Acta Pharm. 2013 Sep;63(3):335-58. doi: 10.2478/acph-2013-0021. Acta Pharm. 2013. PMID: 24152895 Review.
-
Ester-Based Hydrophilic Cyclodextrin Nanosponges for Topical Ocular Drug Delivery.Curr Pharm Des. 2016;22(46):6988-6997. doi: 10.2174/1381612822666161216113207. Curr Pharm Des. 2016. PMID: 27981908
Cited by
-
Cyclodextrin-Based Nanosponges: Overview and Opportunities.Front Chem. 2022 Mar 24;10:859406. doi: 10.3389/fchem.2022.859406. eCollection 2022. Front Chem. 2022. PMID: 35402388 Free PMC article. Review.
-
The Emerging Role of Exosomes in Cancer Chemoresistance.Front Cell Dev Biol. 2021 Oct 28;9:737962. doi: 10.3389/fcell.2021.737962. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34778252 Free PMC article. Review.
-
Nanosponge-C3N4 composites as photocatalysts for selective partial alcohol oxidation in aqueous suspension.Photochem Photobiol Sci. 2023 Jul;22(7):1517-1526. doi: 10.1007/s43630-023-00394-5. Epub 2023 Feb 27. Photochem Photobiol Sci. 2023. PMID: 36847924
-
Recent Advances in Potential Health Benefits of Quercetin.Pharmaceuticals (Basel). 2023 Jul 18;16(7):1020. doi: 10.3390/ph16071020. Pharmaceuticals (Basel). 2023. PMID: 37513932 Free PMC article. Review.
-
Nanoparticle delivery of cardioprotective therapies.Cond Med. 2020 Feb;3(1):18-30. Cond Med. 2020. PMID: 34268485 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources